| |
|
|
|
|
| Slide Lecture Programs |
| 2003 Core Curriculum |
Impact of vascular biology in treatment of cardiovascular disease
Section V: Atrial fibrillation, anticoagulation, and stroke prevention |
December 31, 2003
|
| A-1: |
Epidemiology update: Scope of the problem
- The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study was a cross-sectional prevalence study in adults who were enrolled in a large California health maintenance organization (Kaiser Permanente of Northern California).1
- In the study population of 1.89 million, a diagnosis of AF was entered in the medical records of 17,974 patients (0.95%) between July 1, 1996 and December 31, 1997.
- The prevalence of AF was greater in men than in women, and increased with age in both groups.
1Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. JAMA.2001;285:2370-2375.
|
|
|
Resources